Overview
ZTS market data
Price History
ZTS price chart · 1M
- O
- 76.30
- H
- 76.60
- L
- 75.09
- C
- 75.31
- Vol
- 147,952.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $76.30
- Previous Close
- $77.50
- Day High
- $76.60
- Day Low
- $75.09
- 52 Week High
- $115.16
- 52 Week Low
- $70.99
- 7 Day Return
- +0.39%
- 30 Day Return
- -2.84%
- 90 Day Return
- -2.32%
- 1 Year Return
- -33.40%
- Daily Notional Volume
- $11.1M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 11.54 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $6.02 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.74 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 1.6% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 27.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $71.00 – $158.30 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $30.2B · P/B 16.65 · P/S 3.17.
Company News
Global Veterinary Medical Devices Market to Reach $9.1 Billion by 2030, Driven by Rising Pet Ownership and Technological Innovation in Animal HealthcareGlobenewswire Inc · Aug 25, 2026, 7:15 PM
TD Cowen Maintains Buy on Zoetis, Lowers Price Target to $94Benzinga · Aug 25, 2026, 2:10 PM
Stifel Maintains Hold on Zoetis, Lowers Price Target to $80Benzinga · Aug 20, 2026, 1:07 PM
FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and PuppiesBenzinga · Aug 13, 2026, 5:09 PM
BNP Paribas Maintains Outperform on Zoetis, Lowers Price Target to $110Benzinga · Aug 11, 2026, 5:57 PM
Piper Sandler Maintains Neutral on Zoetis, Lowers Price Target to $80Benzinga · Aug 10, 2026, 6:36 PM
UBS Maintains Neutral on Zoetis, Lowers Price Target to $80Benzinga · Aug 7, 2026, 11:31 PM
JP Morgan Maintains Overweight on Zoetis, Lowers Price Target to $115Benzinga · Aug 7, 2026, 6:28 PM
Zoetis Sees Softer Pet Health Demand, But Adapting Commercial Strategy to Navigate HeadwindsBenzinga · Aug 6, 2026, 6:10 PM
William Blair Downgrades Zoetis to Market PerformBenzinga · Aug 6, 2026, 4:39 PM